1.Application of small intestine double stoma and succus entericus reinfusion in the patients with severe intra-abdominal infection.
Jinguo ZHU ; Jian WANG ; Yuan HE ; Haiwen ZHUANG ; Jinyun YANG
Chinese Journal of Gastrointestinal Surgery 2015;18(7):667-670
OBJECTIVETo evaluate the application of small intestine double stoma and succus entericus reinfusion in the patients with severe intra-abdominal infection.
METHODSTen patients with high intestinal perforation from February 2005 to November 2014 were enrolled in the study. All the cases received emergency operation. Small bowel with intestinal perforation was resected, and double stoma was applied in the proximal and distal small intestine. When abdominal infection under control, total enteral nutrition was successfully administered from nasogastric tube. The succus entericus from the proximal intestine was collected and transfused back to the distal intestine. Stool was collected and fecal nitrogen, fat and carbohydrate contents were determined. Related serum protein levels were measured.
RESULTSAs compared to pre-reinfusion, the absorption rate of carbohydrate [(90.9±7.8)% vs. (82.7±15.2)%], fat [(87.6±6.4)% vs. (59.1±10.8)%], and nitrogen [(82.4±9.8)% vs. (67.2±15.4)%] increased after succus entericus reinfusion (P<0.05). The serum protein levels increased significantly as well[fibronectin: (285.6±3.6) vs. (157.0±22.6) mg/L, P<0.01; transferrin: (4.86±0.21) vs. (3.60±0.25) g/L, P<0.05; pre-albumin: (291.3±112.5) vs. (199.1±53.3) mg/L, P<0.05].
CONCLUSIONSmall intestine double stoma and succus entericus reinfusion are effective in improving the absorption of carbohydrate, fat and nitrogen in the patients with severe intra-abdominal infection.
Enteral Nutrition ; Humans ; Intestinal Perforation ; Intestinal Secretions ; Intestine, Small ; Intraabdominal Infections ; Surgical Stomas
2.Helicobacter pylori Vacuolating Toxin Exhibits Polar Activity of Cl Secretion and Secretory Response to Carbachol in T84 Cells.
Nan Ge JIN ; Yong Ri JIN ; Insuk SO ; Ki Whan KIM
The Korean Journal of Physiology and Pharmacology 2004;8(5):289-293
To investigate whether VacA (vacuolating toxin) produced by Helicobacter pylori Korean stain 99 induces intestinal secretion, purified VacA was added to T84 cell monolayers mounted in Ussing chambers, and electrical parameters were monitored. Mucosal addition of low pH-pretreated VacA increased short circuit current (Isc). The effect was time- and dose-dependent and saturable. The time-to-peak Isc was concentration-dependent. Chloride channel inhibitors, niflumic acid or 5- nitro-2- (3-phenylpropylamino) -benzoate (NPPB), inhibited VacA-stimulated Isc. Carbachol (CCh) -induced increase of Isc was prolonged by the addition of VacA to the mucosal side only. The effect was unaltered by the addition of niflumic acid. VacA did not show cytopathic effects. These studies indicate that VacA is a nonlethal toxin that acts in a polar manner on T84 monolayers to potentiate Cl secretion and the response to CCh secretion without decrease in monolayer resistance. VacA may contribute to diarrhea diseases in human intestinal epithelial cells.
Carbachol*
;
Chloride Channels
;
Diarrhea
;
Epithelial Cells
;
Helicobacter pylori*
;
Helicobacter*
;
Humans
;
Intestinal Secretions
;
Niflumic Acid
3.cAMP-dependent signalling is involved in adenosine-stimulated Cl- secretion in rabbit colon mucosa.
Sae Ock OH ; Eui Yong KIM ; Jin Sup JUNG ; Jae Skuk WOO ; Yong Keun KIM ; Sang Ho LEE
The Korean Journal of Physiology and Pharmacology 1998;2(4):521-527
An important property of the intestine is the ability to secrete fluid. The intestinal secretion is regulated by a number of substances including vasoactive intestinal peptide (VIP), ATP and different inflammatory mediators. One of the most important secretagogues is adenosine during inflammation. However, the controversy concerning the underlying mechanism of adenosine-stimulated Cl- secretion in intestinal epithelial cells still continues. To investigate the effect of adenosine on Cl- secretion and its underlying mechanism in the rabbit colon mucosa, we measured short circuit current (ISC) under automatic voltage clamp with DVC-1000 in a modified Ussing chamber. Adenosine, when added to the basolateral side of the mucosa, increased ISC in a dose-dependent manner. The adenosine-stimulated ISC response was abolished when Cl- in the bath solution was replaced completely with gluconate. In addition, the ISC response was inhibited by a basolateral Na-K-Cl cotransporter blocker, bumetanide, and by apical Clchannel blockers, dephenylamine-2-carboxylate (DPC), 5-nitro-2-(3-phenyl-propylamino)-benzoate (NPPB), glibenclamide. Amiloride, an epithelial Na+ channel blocker, and 4,4-diisothiocyanato-stilbene-2,2-disulphonate (DIDS), a Ca2+-activated Cl- channel blocker, had no effect. In the mucosa pre-stimulated with forskolin, adenosine did not show any additive effect, whereas carbachol resulted in a synergistic potentiation of the ISC response. The adenosine response was inhibited by 10 micrometer H-89, an inhibitor of protein kinase A. These results suggest that the adenosine-stimulated ISC response is mediated by basolateral to apical Cl- secretion through a cAMP-dependent Cl- channel. The rank order of potencies of adenosine receptor agonists was 5'-(N-ethylcarboxamino)adenosine(NECA) > N6-(R-phenylisopropyl)adenosine(R-PIA)>2-(p-(2-carbonylethyl)-phenyl-et hylamino)-5'-N-ethylcarboxaminoadenosine(CGS21680). From the above results, it can be concluded that adenosine interacts with the A2b adenosine receptor in the rabbit colon mucosa and a cAMP-dependent signalling mechanism underlies the stimulation of Cl- secretion.
Adenosine
;
Adenosine Triphosphate
;
Amiloride
;
Baths
;
Bumetanide
;
Carbachol
;
Colforsin
;
Colon*
;
Cyclic AMP-Dependent Protein Kinases
;
Epithelial Cells
;
Glyburide
;
Inflammation
;
Intestinal Secretions
;
Intestines
;
Mucous Membrane*
;
Purinergic P1 Receptor Agonists
;
Receptors, Purinergic P1
;
Vasoactive Intestinal Peptide
4.Lubiprostone Increases Small Intestinal Smooth Muscle Contractions Through a Prostaglandin E Receptor 1 (EP1)-mediated Pathway.
Walter W CHAN ; Hiroshi MASHIMO
Journal of Neurogastroenterology and Motility 2013;19(3):312-318
BACKGROUND/AIMS: Lubiprostone, a chloride channel type 2 (ClC-2) activator, was thought to treat constipation by enhancing intestinal secretion. It has been associated with increased intestinal transit and delayed gastric emptying. Structurally similar to prostones with up to 54% prostaglandin E2 activity on prostaglandin E receptor 1 (EP1), lubiprostone may also exert EP1-mediated procontractile effect on intestinal smooth muscles. We investigated lubiprostone's effects on intestinal smooth muscle contractions and pyloric sphincter tone. METHODS: Isolated murine small intestinal (longitudinal and circular) and pyloric tissues were mounted in organ baths with modified Krebs solution for isometric recording. Basal muscle tension and response to electrical field stimulation (EFS; 2 ms pulses/10 V/6 Hz/30 sec train) were measured with lubiprostone (10(-10)-10(-5) M) +/- EP1 antagonist. Significance was established using Student t test and P < 0.05. RESULTS: Lubiprostone had no effect on the basal tension or EFS-induced contractions of longitudinal muscles. With circular muscles, lubiprostone caused a dose-dependent increase in EFS-induced contractions (2.11 +/- 0.88 to 4.43 +/- 1.38 N/g, P = 0.020) that was inhibited by pretreatment with EP1 antagonist (1.69 +/- 0.70 vs. 4.43 +/- 1.38 N/g, P = 0.030). Lubiprostone had no effect on circular muscle basal tension, but it induced a dose-dependent increase in pyloric basal tone (1.07 +/- 0.01 to 1.97 +/- 0.86 fold increase, P < 0.05) that was inhibited by EP1 antagonist. CONCLUSIONS: In mice, lubiprostone caused a dose-dependent and EP1-mediated increase in contractility of circular but not longitudinal small intestinal smooth muscles, and in basal tone of the pylorus. These findings suggest another mechanism for lubiprostone's observed clinical effects on gastrointestinal motility.
Alprostadil
;
Animals
;
Baths
;
Chloride Channels
;
Constipation
;
Contracts
;
Dinoprostone
;
Gastric Emptying
;
Gastrointestinal Motility
;
Humans
;
Intestinal Secretions
;
Intestine, Small
;
Isotonic Solutions
;
Mice
;
Muscle Tonus
;
Muscle, Smooth
;
Muscles
;
Pylorus
;
Receptors, Prostaglandin E
;
Receptors, Prostaglandin E, EP1 Subtype
;
Lubiprostone
5.Study on in vitro release empirical method and the release mechanism of budesonide colonic localization tablet.
Hui LIU ; Wei-San PAN ; Shu-Fang NIE ; Xing-Gang YANG ; Ting-Xu YAN
Acta Pharmaceutica Sinica 2008;43(11):1147-1151
The three-step dissolution experiment was established to investigate the in vitro release of budesonide colon-specific tablet and to elucidate the drug release mechanism by fitting to different mathematical models. The physiological parameters of stomach, small intestine and colon such as pH value, intestinal flora, specific organic enzyme, vermiculation and conveying time were mimicked to plot the in vitro dissolution, separately. Sample were taken at predetermined time intervals in 24 h and the accumulated drug releases were determined by using HPLC method. Drug release curves of the localization tablets were fitted to various mathematical models. It shows that no drug release was found in 2 h. About 5% release was determined after 6 h while 77.5% accumulated release was reached within 24 h. Drug release from the in house formulation fitted well into first-order model. The three-step dissolution method could be used to evaluate the colon-specific characteristics of budesonide colonic localization tablet. The drug release behavior of the localization tablet conforms to the drug release mechanisms of controlled porosity osmotic pump where osmotic pressure is the main driving force for controlled delivery of drugs.
Animals
;
Anti-Inflammatory Agents
;
administration & dosage
;
pharmacokinetics
;
Budesonide
;
administration & dosage
;
pharmacokinetics
;
Colon
;
metabolism
;
Delayed-Action Preparations
;
Drug Carriers
;
Drug Compounding
;
Drug Delivery Systems
;
methods
;
Excipients
;
Hydrogen-Ion Concentration
;
In Vitro Techniques
;
Intestinal Secretions
;
Models, Theoretical
;
Rats
;
Tablets
6.Effects of rhubarb on the immune substances secreted from intestine in mice.
Nan XU ; Xiao-Li CHEN ; Ling-Jun LU ; Sang-Zhu CIREN
China Journal of Chinese Materia Medica 2005;30(18):1441-1443
OBJECTIVETo investigate the therapeutic mechanism of rhubarb in protecting the intestinal muco-membranous barrier in the mice.
METHODBal b/c mice were divided into 2 groups, gavaged with normal saline and 10% rhubarb decoction, respectively. The animals were killed after 24 hours after the treatments. The intestinal juice was collected after intestinal lavage and centrifuged for determination of IgA, total protein, C3, high density lipoprotein, type II PLA2 activity, and content of lysozyme. At the same time, 40 mg of small intestine were incised in each mouse. Reverse transcription polymerase chain reaction (RT-PCR) and gel image analysis were performed to detect the content of the cryptdin gene expression.
RESULTThe content of IgA, total protein, the C3, lysozyme, and the type II PLA2 activity in intestinal lavaged juice exhibited the statistical differences between the two groups (P < 0.05). There were no significant difference in the ontents of HDL, cryptdin-1 and cryptdin-4 gene expression between the two groups (P > 0.05).
CONCLUSIONRhubarb could increase secretion of several immune associated substances of the mucous membrane in normal intestine, indicating a possibility to abate the injury of intestine mucus resulted from severe stress induced by trauma, burn and shock. Through above mechanisms Rhubarb may also reduce the incidence of bacterial translocation and systemic inflammatory reaction syndrome (SIRS).
Animals ; Complement C3 ; metabolism ; Drugs, Chinese Herbal ; isolation & purification ; pharmacology ; Group II Phospholipases A2 ; Immunoglobulin A ; metabolism ; Intestinal Mucosa ; metabolism ; Intestinal Secretions ; metabolism ; Intestine, Small ; metabolism ; Mice ; Mice, Inbred BALB C ; Muramidase ; metabolism ; Phospholipases A ; metabolism ; Phospholipases A2 ; Plants, Medicinal ; chemistry ; Proteins ; metabolism ; Rheum ; chemistry
7.Study on stability of major pharmaceutical ingredients of vladimiriae radix before and after being roasted in artificial gastric juice, artificial intestinal juice and isolated rat gastric, intestinal or colonic incubation juice.
Qian MAO ; Chaomei FU ; Huiling HU ; Zhanguo WANG ; Yao HE ; Xifu BAO
China Journal of Chinese Materia Medica 2012;37(6):785-789
OBJECTIVETo study the stability of costunolide (COS) and dehydrocostus lactone (DEH) of Vladimiriae Radix before and after being roasted in artificial gastric juice, artificial intestinal juice and isolated rat gastric, intestinal or colonic incubation juice.
METHODThe HPLC method was used for the determination of the mass concentration of COS and DEH Vladimiriae Radix before and after being roasted artificial gastric juice, artificial intestinal juice and isolated rat gastric, intestinal or colonic incubation juice. The samples were incubated with isolated rat stomach, small intestine; colon was used to study physical adsorption, absorption or degradation parameters.
RESULTCOS of Vladimiriae Radix before or after being roasted was unstable in artificial gastric juice, with the average degradation constants as 0.758 0 and 0.531 1. Having been roasted, it showed an increasing stability with a significant difference (P < 0.01). Both of COS and DEH of Vladimiriae Radix before or after being roasted showed high adsorption, uptake or degradation (2 h), and it had significant difference between different parts.
CONCLUSIONCOS was unstable in artificial gastric juice (unprocessed Vladimiriae Radix has a higher degradation rate). Isolated rat stomach, small intestine, colon can adsorb, take, degrade COS and DEH of Vladimiriae Radix before or after roasting process obviously and differently. It provides basis for studies on the absorption mechanisms of effective ingredients of Vladimiriae Radix before and after being roasted.
Animals ; Asteraceae ; chemistry ; Chromatography, High Pressure Liquid ; Colon ; metabolism ; Drug Stability ; Drugs, Chinese Herbal ; chemistry ; isolation & purification ; Gastric Juice ; chemistry ; Intestinal Secretions ; chemistry ; Intestines ; metabolism ; Lactones ; analysis ; chemistry ; pharmacokinetics ; Male ; Plants, Medicinal ; chemistry ; Rats ; Rats, Wistar ; Sesquiterpenes ; analysis ; chemistry ; pharmacokinetics ; Stomach ; metabolism